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Abstract Lymes disease (LD) caused by bacteria in the Borrelia genus is the most commonly known vector borne disease on the northern hemisphere. There are at least 10 human pathogenic Borrelia species known to date, five of which have been identified in Norwegian ticks. Diagnosis of LD is routinely done by serological tests such as ELISA. However, this method of diagnosis is not well suited to distinguish between a wide range of LD symptoms and the disease causing bacterial species. Serological tests are dependent on an immune response, which may not always occur. Furthermore the immune response is a slow process, typically occurring 6 weeks after infection. A direct method of detection based on DNA typing would potentially allow earlier detection of bacterial infection as well as identify the actual disease causing Borrelia species.   Currently there is no direct testing method commercially available, and the Borrelia bacteria have proven difficult to work with. In the scientific community, there is controversy as to which is the most optimal sample material for bacterial DNA isolation, as well as which method of detection is the most suitable to apply. In this thesis the development of a direct detection method for the Borrelia bacteria by the hbb gene for a histone-like protein in human plasma and serum samples with real-time PCR (qPCR) was attempted.   Blood samples from medical patients who had tested positive for LD with ELISA antibody detection was used for isolation of Borrelia bacteria. The hbb-gene used for primer and probe design is highly conserved between species of Borrelia bacteria. A sufficient extraction method and qPCR optimisation was considered essential for 
Borrelia detection.  
Borrelia was not detected in any of the samples tested. Both the DNA extraction and the qPCR assay applied for the testing needs to be further optimised. If we had succeeded in isolating bacterial DNA from blood samples, we would have proceeded to develop a melting curve qPCR analysis to distinguish between different strains of the disease causing bacteria.   
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1 Introduction 
1.1 Background Lyme disease (LD) is the most common vector borne disease in the northern hemisphere. LD is known to spread through ticks in the Ixodes family (Tijsse-Klasen, Sprong, & Pandak, 2013). In Norway LD has become endemic as far north as Brønnøysund (63°), and has also been found sporadically above the Arctic Circle (71°) (Kjelland, Stuen, Skarpaas, & Slettan, 2010). LD is caused by at least 10 Borrelia species, where B. burgdorferi, B. afzelii and B. garinii are the most common in Norway (Kjelland et al., 2010). LD is as diverse as the bacteria causing it, the symptoms may include a bulls eye rash called erythema migranes (EM), muscle stiffness, pain in joints, face palsy, headache and if left untreated arthritis often occur (Murray & Shapiro, 2010). LD is treated with antibiotic therapy.  Diagnosis of LD is done by indirect serological tests like Enzyme-Linked Immunosorbent Assay (ELISA) and western blot (WB) that detect antibodies produced by an infected person. The antibodies are produced by the immune system after the onset of an infection. This is a slow process and can take up to 6 weeks, before this false negatives can occur (Mygland et al., 2010). Serological tests are less specific than tests based on detecting the Borrelia spirochete directly. The ELISA and WB tests can detect an infection, but they cannot differentiate between different bacteria causing LD. Furthermore, it can be difficult to assign symptoms to a specific LD causing bacteria.   A method of detecting the Borrelia bacteria directly in human blood samples has proven to be difficult. Borrelia bacteria thrive in tissues and are not abundant in the blood (Committee on Lyme Disease and Other Tick-Bourne Diseases, 2011). However Borrelia DNA isolation from human blood has been done (Aguero-Rosenfeld, Wang, Schwartz, & Wormser, 2005; Santino, Berlutti, Pantanella, Sessa, & del Piano, 2008). PCR testing of erythema migranes skin biopsies have also been successful, but it´s more expensive and invasive than the serological tests. In addition the EM rash is not always present (Tijsse-Klasen et al., 2013). The cerebrospinal fluid (CSF) has also been tested with PCR in some cases if a patient displays neurological symptoms like facial palsy with varying success 
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(Gooskens, Templeton, Claas, & van Dam, 2006; Kruger & Pulz, 1991). Because of the parasitic lifestyle of the bacteria cultivating it on medium is difficult. They require an expensive nutrient rich growth medium and even then it takes up to 16 weeks to get colonies, even in the right conditions it is difficult to grow (Sapi et al., 2013). To grow the spirochetes from human serum and plasma samples is tedious work, and thus less useful as a diagnostic tool. Also it is likely that the spirochete will express itself different in the human body than in a culture or in the tick.   In this thesis I will try to detect Borrelia directly in human blood samples using real-time polymerase chain reaction (qPCR) and distinguish the different Borrelia bacteria by making a melting curve analysis. The qPCR setup is adapted from an article by Portnoi et 
al. (2006). His group cultivated Borrelia bacteria on growth medium and analysed them with qPCR using a sequence from a histone-like protein called hbb that is conserved among the most common disease inducing Borrelia spirochetes in Eurasia (Valsangiacomo, Balmelli, & Piffaretti, 1997). The research team was able to make a successful melting curve analysis that I will try to reproduce using human blood samples. Bacterial detection by qPCR from a blood sample would be specific for LD causing bacteria, and could differentiate between the different known Borrelia spirochetes.    The blood samples are anonymously donated and was provided by Dr. Med. D. Øgreid from Kolibri medical. The research project was approved by the regional Ethic committee (REK, appendix 5). The samples were IgM and IgG positive by serological testing.        
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1.2   Borrelia sensu stricto complex 
Borrelia Sensu stricto complex is a diverse group of bacteria. According to the National Centre for Biotechnology Information (NCBI) 37 species of Borrelia is classified at present time. At least 10 of these are pathogenic to humans; B. burgdorferi, B. afzelii, B. 
garinii, B. miyamotoi, B. valaisiana, B. bavariensis, B. bissettii, B. spielmanii, B. lusitaniae and B. kurtenbachii, respectively (Rudenko, Golovchenko, Grubhoffer, & Oliver, 2011). The different species of Borrelia is geographically restricted since they are dependent on ticks in the Ixodes family and their vertebrate hosts for pathogenesis (Rudenko et al., 2011). In USA, B. burgdorferi is the main cause of LD. In Norway and in the rest of Eurasia the disease picture is more complex, B. afzelii, B. garinii, B. burgdorferi, B. 
valaisiana and the recently discovered B. miyamotoy can all cause LD in Norway (Kjelland et al., 2010; Kjelland, Rollum, Korslund, Slettan, & Tveitnes, 2015).  The Borrelia bacteria are members of the phylum spirochetes. They have a characteristic spiral structure comprised of a cylinder shaped protoplasmic space covered by an inner and outer membrane. In between the membrane layers there is a periplasmic space containing a peptidoglycan layer and flagellar filaments (Figure 1.1) (Merilainen, Herranen, Schwarzbach, & Gilbert, 2015). Unique for the spirochete is their internal flagella, unlike external flagella the periplasmic flagella gives the spirochete its shape in addition to aid in its movements. It moves in a corkscrew motion, which helps the bacteria to bore into tissues and makes it move efficiently in viscous liquids (Strelkauskas, Strelkauskas, & Moszyk-Strelkauskas, 2009).    
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Figure 1.1: Borrelia spirochete .  Reproduced with the permission of Pearson Education, inc.   The spirochetes can survive in several different host animals and evade their immune system (Singh & Girschick, 2004). Many different outer surface proteins (Osp) play a major role in the success of LD. They have the ability to up- and down regulate the different surface proteins when needed (Schwan, Piesman, Golde, Dolan, & Rosa, 1995). The spirochete express little Osp A in a mammalian host, but it is heavily present in the tick host (Crowley & Huber, 2003). Some surface proteins like Osp C are regulated by temperature (Kenedy, Lenhart, & Akins, 2012; Stevenson, Schwan, & Rosa, 1995). The ability to regulate Osp expression may play a role in the establishment of LD in different species. Almost 15% of its plasmid DNA and 5% of the chromosomal DNA encodes for outer surface proteins (Templeton, 2004).  The genome for Borrelia burgdorferi is very segmented and difficult to manipulate (Kung, Anguita, & Pal, 2013). It consists of a larger chromosomal genome and up to 21 linear and circular plasmids, the GC percentage in the entire genome is lower than 30% (Brisson, Drecktrah, Eggers, & Samuels, 2012). Like a true parasite, Borrelia DNA encodes for very little metabolites, and it’s dependent on a host to survive (Brisson et al. 2012). This trait makes it difficult to culture the bacteria, since they need a growth medium high in nutrients.  
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 The Borrelia bacteria thrive in host tissues like the skin, joints and hart (Schwarz et al., 2012). It can also cross the blood-brain barrier and enter the central nervous system (CNS) (Pulzova et al., 2011). There is some speculation if a correlation is possible between bacteria and Alzheimer disease (AD). Borrelia spirochetes have been found in brain biopsies from people who suffered from AD (Miklossy, 2011).  Eva Sapi a researcher from Newhaven University argues that Borrelia spirochetes has the ability to make biofilm and cysts in vivo (Sapi et al., 2012). She was successful in making biofilm in vitro. Cystic forms of Borrelia spirochetes have also been made and reverted back to a vegetative state in vitro by inducing unfavourable conditions. If the 
Borrelia spirochete has the ability of biofilm and cyst formation, a short antibiotic cure might not be sufficient to cure LD.     
1.2   Lifecycle and prevalence of Ixodes ticks LD is a zoonotic disease dependent on ticks in the Ixodes family for propagation. In Europe I. ricinus is the most common vector organism (Schwarz et al., 2012). I. ricinus are a species found along the coast of Norway. Their lifecycle consists of four stages, egg, larvae, nymph and adult (Figure 1.2). With the exception of the egg stage they need a blood meal to advance to every new life stage, meaning a tick can be a vector organism for Borrelia spirochetes as early as in the larvae stage (Schwarz et al., 2012).  
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Figure 1.2: I l lustration of the tick life cycle and transmission route of Borrelia spirochetes .  
Reproduced with permission from Centres for Disease Control Division of Vector-Borne 
Infectious Diseases: Lyme Disease Transmission .  
(http://www.cdc.gov/ncidod/dvbid/lyme/ld_transmission.htm.)  The spirochetes are located in the mid-gut in the tick and moves up to the salivary glands during a blood meal to be transferred to a new host organism. The ticks can feed on a wide range of vertebrate hosts which becomes infected as well as reservoirs for LD. qPCR has been used in analysis of Borrelia-infected ticks and the results indicates that different spirochetes have a vertebrate host preference. B. garinii and B. valaisiana is associated with birds, B. garinii with small rodents and B. burgdorferi with roe deer (Dubska, Literak, Kocianova, Taragelova, & Sychra, 2009; Margos, Vollmer, Ogden, & Fish, 2011).    
6  
 
1.4   Lyme disease (LD) LD also known as borreliosis or lyme borreliosis has existed for a long time, Ötzi the iceman mummy who lived around 3300B.C is the first recorded human with LD (Hall, 2011). LD is a multi-systemic inflammatory disease (Wilhelmsson et al., 2013). The first clinical manifestation of LD is often a bull’s eye rash called erythema migranes (EM) which presents itself after 3-30 days, the rash can look like a bulls eye hence the common name (Murray & Shapiro, 2010). However there is a disagreement on how often the rash presents itself in borreliosis patients, it varies from 60-90% according to different sources (Murray & Shapiro, 2010; Norwegian health directorate, 2009). Therefore it is not common to make a diagnosis solely based on the presence of EM. Flu like symptoms often accompanies the rash. LD is associated with several symptoms, which becomes more severe if antibiotic treatment is not started. Face palsies can occur, meningitis like symptoms, radiculoneuritis, memory loss and impairment of motor or sensory functions are some of the many symptoms that may occur. Solely based on the clinical assessment LD is very similar to other autoimmune diseases.   Different Borrelia spirochetes are associated with different symptoms. B. burgdorferi is associated with arthritis, B. garinii with neuroborreliosis and B. afzelii with dermatoborreliosis (Kjelland et al., 2010). Current standard diagnostic tests cannot differentiate between the Borrelia spirochetes infecting patients making it difficult to be certain. This is one reason why it’s important to develop a melting curve analysis for 
Borrelia spirochetes and this is possible with qPCR analysis.  
1.4.1 Chronic borreliosis or Post Lyme disease Chronic borreliosis is a controversial diagnosis and is currently not accepted as a disease in the Norwegian health community. After antibiotic treatment there are some patients who claim they are not fully recovered. Many physicians call this condition Post-Treatment Lyme Disease Syndrome (PTLDS). The cause of PTLDS is not well understood, it is believed to be damage on tissues by the immune system, and some doctors argue it’s a psychotic condition caused by depression and that it has nothing to do with LD at all (Aucott, Rebman, Crowder, & Kortte, 2013). Symptoms for PTLDS may 
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include fatigue, widespread pain, sleep disturbance and memory loss (Aucott et al., 2013).  However, if the research on biofilm and cyst formation can be proven in vivo a short antibiotic treatment might not cure LD, and a chronic form of the disease could develop (Sapi et al., 2012). A qPCR test on human blood samples would be able to detect whether the infection current. This is difficult with the current diagnostic tests.   
1.5 Diagnosis of Lyme disease in Norway LD is diagnosed by serological tests like ELISA and WB. In Norway it’s less common to confirm a positive test with WB, but in for instance USA and Germany it is practiced. Unfortunately serological tests are associated with several shortcomings. They don’t detect the bacteria, but instead rely on antibodies produced by the immune system against infection. It is no way of knowing based on serological tests which Borrelia bacteria a patient is infected with. Both ELISA and WB detect immunoglobulin M (IgM) and immunoglobulin G (IgG) antibodies that the body produce after the onset of the disease. For a positive result both IgM and IgG must be present, and for this to happen can take up to 6 weeks (Mygland et al., 2010). In the incubation period false negative results are a concern. IgM antibodies are produced early in the infection, this antibody is not specific for LD, and can be produced by an autoimmune disease (Racine et al., 2011). IgG is produced later in the course of the illness and can be present in the body many years after a patient recovers from the disease (Nadelman & Wormser, 2007). Some people do not produce antibodies as a response to the bacteria (Murray & Shapiro, 2010). The serological tests are therefore not very specific, and false positives and false negative responses can occur.  The Borrelia spirochete is seldom cultured in diagnostic labs. To grow the Borrelia bacteria in growth medium is slow and tedious work. The spirochete needs a nutrient rich growth medium modified from the Barbour-Stoenner-Kelly (BSK). Eva Sapi from the New Haven University improved cultivation of Borrelia spirochetes from human serum samples in 2013, however it took 16 weeks to get a 94% positive result from the control group (Sapi et al., 2013).  
8  
qPCR can detect the bacteria itself based on a DNA/RNA segment. And it’s possible to differentiate between the different species of Borrelia in addition to prove an on going disease. qPCR is sometimes used in diagnosis of LD, but because of low efficiency it is not common (The national academies, 2011). qPCR has potential, but needs improvement to become a new diagnosis method. 
1.6 Hbb histone-like protein The hbb-gene sequence for a histone-like protein was used to design the primer and probe. Because of its close interactions with the genome it is highly homologous between Borrelia species (Portnoi et al., 2006; Valsangiacomo et al., 1997). A synthetic 171bp fragment from the 327bp hbb gene was utilized as a positive control (table 1.1). The synthetic plasmid DNA was made by Life technologies. Reference gene sequence and accession number is enclosed in appendix 1.  
 
Table 1.1:  Hbb positive control. For complete reference sequence see appendix 1.  
Hbb Positive control Sequence oligo (5`-…-3`) GCTATTAAAGTAAGGAAATTAGTTTATGTCTTTTTCAAGAAGACCAAAGGTTACTAAGTCAGACATTGTTGATCAAATAGCTTT
GAATATTAAAAATAATAATCTGAAATTAGAAAAAAAATACAT
AAGACTTGTAATAGATGCTTTTTTTGAAGAGCTTAAAAGTAA
TCT  
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2 Aims for the study The main objective for this thesis was to develop a qPCR assay for the precise, fast and sensitive detection of Borrelia bacteria in human serum and plasma samples. First of all the qPCR setup must be optimized then a sufficient DNA extraction method must be achieved.     If this is accomplished the next aim is to develop a melting curve analysis to differentiate between the most common Borrelia species in Norway. The spirochetes are not abundant in the blood therefore it is important that the test can detect even the smallest amounts of Borrelia bacteria. As a positive control, a conserved sequence in the histone-like protein hbb was used (Portnoi et al., 2006). A succsessfull melting curve analysis was made by Portnoi et al. (2006), who detected Borrelia bacteria with qPCR by the hbb gene, and ran a SYBR® Green assay on the qPCR product. The result showed that different Borrelia species had different Tm (Table 2.1).     
Table 2.1: Melting curve results for Borrelia species .  Listed is the Tm  for the Borrelia 
strains, results provided from Portnoi et al. (2006).   
Species Tm  (C°) 
B. afzelii (VS461) 64.13 ± 0.41 
B. garinii (20047) 51.60 ± 0.07 
B. burgdorferi (B31) 67.80 ± 0.09 
B. valaisiana (VS116) 58.80 ± 0.14 
B. lusitaniae (PotiB2) 63.23 ± 0.47 
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3 Methods 
3.1 Sample material Gena collected blood samples at Kolibri medical twice a week, the blood samples were taken in EDTA and gel tubes. At Gena the plasma and serum were transferred to 
Eppendorf tubes in 200μl and 600μl samples and stored in a -20°C freezer. The samples were never thawed more than once.   
3.2 Hbb  
3.2.1 Plasmid DNA description   
Table 3.1: Short description of plasmid DNA with hbb insertion.  Summary of information 
provided by Life technologies.   
Referance number 1362127 
Designation E. coli K12 (dam+dcm+tonA) 
Gene name Hbb positive ctrl 
Gene size 171bp 
Vector backbone pMA-RQ (ampR) 
Cloning sites Sfil/Sfil 
Quantity 5μg Plasmid DNA 
Stock concentration 0.1μg/μl  The synthetic hbb positive control was made with synthetic oligonucleotides and cloned into pMA-RQ (ampR) using Sfil(361) and Sfil(556) as cloning sites (figure 3.1). The plasmid was then purified from the transformed bacteria and DNA concentration determined by UV spectroscopy. The final product was then verified by sequencing.    
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Figure 3.1:Plasmid map.  Hbb positive control inserted in the Sfi l/Sfi l cloning site in a pMA-RQ 
(ampR) vector.    
3.2.2 Hbb Sequence analysis The hbb positive control sequence was aligned to Borrelia genomes using a Basic Local Alignment Search Tool (BLAST) at the national centre for biotechnology (NCBI) database (http://www.ncbi.nlm.nih.gov). The obtained sequences were then aligned in Clustal x a multiple sequence alignment tool. 
3.3 DNA extraction methods The principle of DNA extraction is to extract the DNA from the rest of the cell components. First the cell membrane and nucleus membrane have to be lysed, and thereafter the proteins and cell components have to be separated from the DNA and remove potential PCR inhibitors. Once the DNA is isolated downstream applications like qPCR can be done.   As a routine DNA extraction was always done with two parallels.  
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3.3.1 QIAamp® DNA Mini Kit  The protocol for blood and body fluid spin protocol in QIAamp® DNA Mini Kit from Qiagen was used to isolate DNA from serum and plasma samples.   Proteinase K and buffer AL were incubated with the sample to ensure cell lysis and protein degradation. The silica-gel membrane in the spin columns absorbs DNA while pH and salt concentration ensures PCR inhibitors to be washed through the column. In the final step Buffer AE elute DNA from the column.   The protocol was modified according to the article written by Girard et al. (2011). The start volume was increased from 200μl to 600μl (Girard, Fedorova, & Lane, 2011). 
Modified QIAamp® DNA Mini Kit protocol 
A start volume of 600μl was used, and volumes of reagents were increased as 
recommended by the protocol for samples larger than 200μl. Both serum and plasma 
samples were utilized. 
1. 60μl proteinase K (20mg/ml, Qiagen) and 34.5μl carrier RNA (1μg/μl, Qiagen) was 
pipetted into the bottom of a 1.5ml micro centrifuge tube. 
2. 660μl Serum/plasma was added to the micro centrifuge tube.  
3. 600μl Buffer AL were mixed with the sample to lyse the cells and adjust conditions 
like salt and pH allowing for optimal DNA binding to the QIAamp membrane spin 
columns. 
4. The incubation time was increased from 10 minutes to 1 hour at 56°C. 
5. The samples were briefly centrifuged to remove drops from inside the lid. 
6. 600μl 100% EtOH was added to the samples and mixed by vortexing for 15 seconds. 
7. The mixture from step 6 was then carefully added to the QIAamp Mini Spin column. 
The caps were closed and the samples centrifuged 8000rpm for 1 min. Because of a 
large initial sample size the mixture from step 6 was centrifuged in two steps using 
the same QIAamp Mini spin column. The collection tube was emptied after each 
centrifugation.  
8. 500μl Buffer AW1 was added to the QIAamp Mini spin columns, the caps were 
closed and the samples centrifuged at 8000rpm for 1 minute. The QIAamp Mini spin 
column was then placed in a clean collection tube. 
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9. 500μl buffer AW2 was added and centrifuged at 13 000rpm for 3 minutes.  
10. The samples was then centrifuged for an additional minute at 13 000 rpm to 
remove all AW2 carryover. 
• Buffer AW1 and AW2 are washing buffers that remove residual contaminants 
without affecting DNA binding. Improving the purity of eluted DNA. 
11. The QIAamp Mini spin column was then placed in a clean collection tube and 50μl 
buffer AE was added and the sample was incubated for 5 minutes at room 
temperature before it was centrifuged at 8000rpm for 1 minute. The QIAamp was 
then placed in a new collection tube and the step repeated once more to elute the 
rest of the DNA. 
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3.3.2 Ammonium hydroxide DNA extraction DNA extraction with ammonium hydroxide is rapid and inexpensive. The protocol used was modified from the article by Santino et al. (2008). DDT, proteinase K and carrier RNA were added and incubated for 1 hour at 56°C.  The DNA precipitation method was changed by adding a step with 100% EtOH instead of 70% EtOH, and the centrifugation after overnight incubation was done for 20 instead of 15 minutes. 
Modified ammonium hydroxide protocol 
100μl serum/plasma samples were used.  
1. 10μl DDT (1M, Sigma-Aldrich®), 10μl Proteinase K (20mg/ml, Qiagen) and 5μl 
carrier RNA (1μg/μl, Qiagen) were added to the 100μl samples. 
2. 200μl Ammonium hydroxide (0.7M, Sigma-Aldrich®, appendix 4) was then added to 
the serum/plasma sample and boiled at 100°C for 5 minutes on a heating block 
(Dry block heating systems, QBD/QBH series, Grant) with the lids closed. 
3. Then the samples were centrifuged quickly to remove droplets from the lid. 
4. The samples were then boiled for an additional 10 minutes at 100°C with the lids 
open. 
DNA precipitation 
5. 650μl 100% EtOH and 32,5μl sodium acetate (3M, Sigma-Aldrich®) were added to 
the samples. 
6. The samples were then left in a -20°C freezer overnight. 
7. The next day the samples were centrifuged for 20 minutes at 13 000rpm  (4°C) 
8. The supernatant was discarded 
9. 100μl 70% EtOH was added  
10.  The samples were centrifuged for 5 minutes at 13 000rpm 
11.  The supernatant was discarded and the pellets were left to dry for approximately 
15 minutes. 
12. The pellets were then re-suspended in 50μl TE-buffer (Appendix 4).  
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3.4 Developing qPCR protocols 
3.4.1 Primer and probe design Primers are short synthetic oligo sequences that bind specifically to a DNA strand and act as a binding site for DNA polymerase to start to synthesize a new DNA strand. Life technologies produce two types of fluorescent dyes TaqMan® and SYBR® Green.  For this thesis TaqMan® MGB probes was utilized.  TaqMan® probes binds to a specific sequence in the template strand.  The probe is bound to a fluorescent reporter dye and a quencher. The quencher will inhibit the reporter dye from exiting a signal when they are close to each other (figure 3.2). Once the DNA polymerase starts to elongate the template strand the TaqMan® probe will hydrolyse and the reporter dye will generate a signal. There are two kinds of TaqMan® probes MGB and non-MGB.   MGB TaqMan® probes has a minor groove binding (MGB) molecule at the 3´end, this molecule increase the probes Tm by strengthening binding to the template strand. This means that these kinds of probes can be shorter than non-MGB probes and still have a higher Tm than longer probes without MGB.   
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Figure 3.2: Taqman probe. The probe and primers binds to the template strand. A quencher 
molecule inhibits the fluorophore/reporter dye until the new DNA strand hydrolyse the probe 
and separates the reporter dye from the quencher allowing it to fluoresce 
(http://en.wikipedia.org/wiki/TaqMan).    
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All primers and probes for this project were designed in Primer Express® version 3.0.1, a software developed by Life technologies. The primers and probes were designed according to Real-time PCR handbook (2014) provided by Life Technologies. The sequences for the primers and probes used are listed in table 3.2. 4bp was added at the start of the hbb positive control. The bp added is not a part of the hbb DNA sequence, but is still highly conserved in Borrelia genome (Appendix 3).  Life primers and probes were designed by Bjørn Rosén a technician from Life technologies. Portnoi primers and probes were based on the same sequences used by Portnoi et al. (2006). See appendix 2 for amplicon binding and length.  
Table 3.2:qPCR primers and probes used for qPCR. All probes were MGB TaqMan® probes with 
FAM™ reporter dye and TAMRA™ quencher.    
Assay  Sequence oligo (5`-…-3`) Tm (°C) 
 Life   Probe 6-FAM-GCT ATT TGA TCA ACA ATG-MGB 69.0 F. primer TGA CTT AGT AAC CTT TGG TCT TCT 52.4 R. primer GTC TTA TGT ATT TTT TTT CTA ATT TCA G 52.3 
 Portnoi Probe 6-FAM- CAA TGT CTG ACT TAG TAA CCT TTG GTC TTC TTG A-MGB 77 F. primer AAA GAC ATA AAC TAA TTT CCT TAC 47.1 R. primer TAA GCT CTT CAA AAA AAG CAT CTA 49.0 
 Modified Portnoi 
Probe 6-FAM-ACC TTT GGT CTT CTT G-MGB 62.0 F. primer AAA GAC ATA AAC TAA TTT CCT TAC TTT AA 49.7 R. primer TAA GCT CTT CAA AAA AAG CAT CTA 49.0  
3.4.2 Real-time PCR TaqMan® Fast Advanced master mix and 96-well clear reaction plates for qPCR were provided by Life Technologies. The hbb positive control was diluted with TE-buffer (Appendix 4).   qPCR was carried out in QuantStudio™ 6 Flex provided by Life technologies, and is based on the same principle as conventional PCR where a target gene sequence is amplified. In qPCR, DNA concentration is measured after each cycle unlike conventional PCR where a 
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post PCR-analysis such as gel-electrophoresis must be done. This enables us to monitor the PCR progress in real time. The amplification normally occurs in three steps denaturation, annealing and extension/elongation, or two steps where the annealing and extension step is combined (table 3.3). According to the real-time PCR handbook (2014) from Life technologies the reaction is usually run for maximum 40 cycles.  
 
Table 3.3:  Description of the steps in qPCR.  The steps for qPCR and PCR are the same. The 
reaction time for each step is amplicon size dependent, generally 1000bp/min for TaqMan DNA 
polymerase (http://en.wikipedia.org/wiki/Taq_polymerase). GC content also increase reaction 
time.  
Denaturation Separation of the two DNA strands at 95°C to disrupt the hydrogen bonds between base pairs.  
Annealing The reaction temperature is lowered to 50-65°C and the primers and probe binds to their template strands. The temperature used in this step depends on the melting temperature (Tm) of the primers. If the temperature is too high the primers cannot bind to the template, but if it’s too low unspecific binding can occur. 
Extension/elongation DNA polymerase adds complementary base pairs to the primers and two new DNA strands are made. The temperature is increased for the DNA polymerase to work optimally. For Taq DNA polymerase the optimal temperature is 72°C.  
Combined annealing and 
extension 
Since the Taq DNA polymerase still function under optimal temperatures although slower a combined annealing and extension step can be done to save time.   In the reaction, a forward and reverse primer and a probe bind to the target sequence. The qPCR machine emits a light at a certain wavelength that will excite a reporter dye on the probe when it’s hydrolysed. The qPCR instrument then measures the change in fluorescence intensity. When the signal exceeds the threshold value, the point of detection is called a threshold cycle (Ct) or quantification point (Cq). The threshold value is set to distinguish relevant amplification signal from the background. The threshold is automatically set at 10 times the standard deviation of the fluorescence value of the 
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baseline. A standard curve can be made based on the Ct value and the known amount of DNA concentration from a control sample. Unknown samples can be calculated using the standard curve and the Ct value. 
 
qPCR Setup for Life primers and probes 
15μl of PCR mix and 5μl of template DNA was added to each well.    The qPCR setup solution used is listed in table 3.4. The final primer and probe 
concentration was 0.9 and 0.25μM, respectively. For the standard curve DNA concentration between 0.1 and 0.0001ng was utilized in a 1:10 dilution series.  
Table 3.4:  qPCR set-up solution for Life primers and probe.   
Reagent  Volume (μl) Final concentration 
TaqMan® Fast Advanced Master Mix 10  
F. primer 1.8 0.9μM 
R. primer 1.8 0.9μM 
Probe 0.5 0.25μM 
Nuclease free water (Sigma-
Aldrich®) 
0.9  
Template DNA 5 0.1-0. 0.0001ng 
Final volume 20   The qPCR program utilized (figure 3.3) was recommended by Rosen and optimized by Elin Skårland Frøyland. 
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Figure 3.3: qPCR program for Life primers and probe. Initial annealing at 50°C for 2 minutes 
and init ial denaturation at 95°C for 20 seconds. Followed by 45 cycles with denaturation at 
95°C for 1 second and a combined annealing and extension step at 52°C for 20 seconds.   Since the qPCR master mix contained Uracil-N-Glycosylase (UNG) an initial solitary annealing step was added to break down unspecific DNA. The initial denaturation step helps denaturation of a larger initial genome size.  
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 qPCR setup for Portnoi and modified Portnoi primers and probes  The qPCR setup was inspired by the article,” A single-run, real-time PCR for detection and identification of Borrelia burgdorferi sensu lato species, based on the hbb gene sequence” (Portnoi et al., 2006).   The Portnoi probe was shortened because of its high Tm. The Portnoi forward primer was elongated with 5bp. The qPCR setup solutions were optimized from the qPCR setup solution used in the article by Portnoi et al. (2006).   
18μl of PCR mix and 2μl of template DNA was added to each well.  A DNA concentration of 200-1ng was used for the standard curve. The setup solution was optimized several 
times, increasing the primer and probe concentration from 0.5 and 0.2μM to 0.9 and 
0.5μM, respectively (table 3.5).  
Table 3.5:  Modified Portnoi qPCR set-up solution.  
Reagent Volume (μl) Final concentration 
TaqMan® Fast Advanced Master Mix 10  
F. primer 1.8 0.9μM 
R. primer 1.8 0.9μM 
Probe 1 0.5μM 
Nuclease free water (Sigma-
Aldrich®) 
3.4  
Template DNA 2 200, 100, 10, 1ng 
Final volume 20    
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Figure 3.4: qPCR program ran in the article by Portnoi et al. (2006). Initial denaturation at 
95°C for 10 minutes followed by 55 cycles with denaturation at 95°C for 8 seconds, Annealing 
at 50°C for 10 seconds and extension at 72°C for 10 seconds.  The qPCR program from Portnoi et al. was the basis of the optimizing steps (Figure 3.4).   Several modification steps were tried. An initial annealing step at 50°C was among others added to activate UNG in the TaqMan® Fast Advanced master mix. The time intervals in each qPCR step were changed one at the time and the annealing temperature was tried altered to optimize primer-binding efficiency (Figure 3.5). 
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Figure 3.5: Modified qPCR program. Initial annealing at 50°C for 2 minutes and init ial 
denaturation at 95°C for 1 second. This was followed with 50 cycles of denaturation at 95°C 
for 4 seconds, annealing at 52°C for 20 seconds and elongation at 72°C for 10 seconds.    
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3.5  Melting curve analysis A melting curve analysis differentiates between the Borrelia bacteria species. The Samples who tests positive for the hbb DNA sequence in the initial qPCR run, will be run again in a new qPCR assay with SYBR® Green. SYBR® Green is a non-specific fluorescent dye who bind to double stranded DNA (dsDNA). The dye binds to the minor groove of dsDNA. Instead of replicating the target sequence any further the temperature where DNA goes from double stranded to single stranded DNA (ssDNA) will be determined. This will be done by a gradual increase in temperature until there is no fluorescence detected by the qPCR sensor. Tm can be calculated based on the resulting graph.    
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4 Results 
4.1 qPCR results The hbb DNA sequence was not detected in any of the patient samples. The modified Portnoi and Life qPCR setups generated standard curves. Portnoi primers and probe did not generate a standard curve with the qPCR setup used by Portnoi et al. (2006).  Based on the standard curve primer binding efficiency was calculated (formula 4.1). The binding efficiency should be 100% ±10%. 100% efficiency corresponds to a slope of         -3.32 (Real-Time PCR handbook, 2014). None of the standard curves produced was within this range.  
E = ((10-1/slope)-1)*100 
Formula 4.1: Primer-binding efficiency.  The slope corresponds to the slope of the standard 
curve. 
4.1.1 Life qPCR setup The amplification plot for Life primers and probe had a threshold line of 0.206 for this qPCR setup (Table 3.4, figure 3.3). The patient sample ran with the same assay did not cross the threshold line (figure4.1). 
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Figure 4.1: Amplification plot for Life qPCR setup. ΔRn  plotted against cycle number. The 
strong background noise is largely due to patient samples. Threshold l ine is 0.206.  Based on the standard curve primer binding efficiency was calculated with formula 4.1 to be 73.2%.  The R2 value, Y-intercept and the slope of the curve are 0.997, 25.22 and  -4.19, respectively (figure 4.2).     
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Figure 4.2: Standard curve for Life qPCR assay.  Cq plotted against Log (DNA concentration). 
The slope of the curve is -4.19. R2 and Y-intercept is 0.997 and 25.22 respectively.   
4.1.2 Modified Portnoi qPCR setup The minimum start concentration of hbb positive control that produced a signal was 1ng. The amplification plot had a threshold line of 0.0889 with the qPCR program ran (table 3.5, figure 3.5).   
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Figure 4.3: Amplification plot for the modified Portnoi qPCR setup.   The generated standard curve had a slope of -10,52 equivalent of a primer binding efficiency of 24,5% (formula 4.1). The Y- intercept and R2 value are 43,112 and 0.992, respectively (figure 4.4).  
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Figure 4.4: Standard curve for the modified Portnoi qPCR setup. The slope of the curve is        
-10,52. R2 and Y-intercept is 0.992 and 43.112, respectively.  
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5 Discussion The main goal for this thesis was to develop a qPCR assay to detect Borrelia by a histone-like protein (hbb gene) in human serum and plasma samples and make a melting curve analysis to differentiate between the different Borrelia species. A method for direct detection of Borrelia bacteria in blood is not commercially available at present, but would be a positive contribution for LD diagnosis and for further Borrelia research.    Development of a sensitive qPCR assay for detection of Borrelia spirochetes in blood samples is more specific than the ELISA test. qPCR can quantify the concentration of bacteria in a sample. It would be able to detect an on-going infection and it would be species-specific giving medical staff the possibility of optimizing treatment and researchers the ability to map the different strains. We chose to design primers and probes by using the histone-like protein hbb gene, because the hbb DNA sequence within the different Borrelia species is conserved (Portnoi et al., 2006; Valsangiacomo et al., 1997). 
5.1 DNA isolation  Serum and plasma were used for DNA isolation of Borrelia bacteria. Borrelia spirochete DNA has previously been extracted from serum and plasma samples, but there are no commercially available methods of direct detection of Borrelia in blood (Aguero-Rosenfeld et al., 2005; Santino et al., 2008; Sapi et al., 2013). The reason for this can be that the amount of circulating spirochetes is low, which makes it difficult to develop a 100% reliable test for direct detection (Eshoo et al., 2012). As mentioned in the introduction the spirochete structure is optimized for boring into tissue and the symptoms associated with the Borrelia bacteria are all associated with different kinds of tissue (Kjelland et al., 2010; Strelkauskas et al., 2009). The spirochetes might be using the blood as a transport highway to different tissues. A larger initial sample volume that is filtered to concentrate Borrelia spirochetes can be worth trying in the future (Aguero-Rosenfeld et al., 2005).   The blood samples tested in this thesis had previously tested positive for LD with ELISA assay. Kolibri medical could not provide additional information about the course of the 
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illness or if antibiotic treatment had been started. This made it difficult to discuss the quality of the blood samples, possibly a vital part of the results of this project.   A good DNA isolation method was considered as the first objective in this thesis. It was important that the extraction method could potentially open Borrelia bacteria in cystic form (Sapi et al., 2012). If the patient who provided the blood sample had started antibiotic treatment there might not be any Borrelia bacteria to detect, or only small amounts of bacteria. The extraction method should therefore be able to concentrate the spirochetes in the serum/plasma samples since there probably is a little amount of spirochetes circulating in the blood.   When a BLAST was done on the hbb gene it became clear that there was several mutations at the binding site for Life primers and probe (appendix 3). When this was discovered the focus was shifted to primer and probe design and qPCR optimisation. If the qPCR assay was not binding to the target sequence it is no way of knowing if the extraction method was good. 
5.2 qPCR analysis The qPCR setup designed for Life primers and probe produced a standard curve with primer binding efficiency of around 72.3%, indicating the need for further optimization.  
Borrelia bacteria were not detected by hbb DNA sequence in any of the plasma or serum samples. Initially it was believed the DNA extraction methods also needed improvement. However the Microbe BLAST of the hbb sequence at ncbi.gov revealed that the binding sites for the primers and probe had several mutations between the different species (appendix 3). The best match was B. burgdorferi B31 with only one mutation site. However B. burgdorferi bacteria are less frequent in Norway than B. afzelii and B. garinii. In a study by Kjelland et al. (2010) 1789 ticks in different life stages were collected all over southern Norway. Only 23.4% were infected with B. burgdorferi, indicating a similar distribution among infected humans. Mismatches between primers and probe and the template DNA strand leads to poor binding efficiency. Because of the BLAST result a new qPCR assay similar to Portnoi et al. (2006) was utilized instead. The qPCR assay had a primer binding efficiency of 83.77% in the article by Portnoi et al. (2006). We hoped this assay could be optimized and transferred to human samples. 
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 The qPCR setup with Portnoi primers and probe generated no standard curve with the 
hbb control. The probe used was an MGB hydrolisation probe giving it a Tm of 77°C. The forward and reverse primer had a Tm of 47.1 and 49.0, respectively. The probe Tm was much higher than the recommended. The probe was therefore shortened from 34 to 16bp and the temperature decreased to 62°C. The primers had Tm difference of 1.9°C which is higher than recommended according to the Real-time PCR handbook (2014). Therefore 5bp were added to the forward primer increasing Tm with 1°C. The 5bp were added in an area where there were no mutations between the Borrelia species according to the hbb microbe BLAST. The primer Tm was still considerably low increasing the risk of unspecific binding. Portnoi et al. (2006) also had low Tm for his primers and probe, but they were able to detected Borrelia with this assay.   The modified Portnoi primers and probe qPCR setup produced a standard curve, but the primer binding efficiency was not within the 90-110% range. Several optimisation steps were attempted. The concentration of hbb positive control DNA used for the standard curve dilution was increased from a start concentration of 1ng to 200ng. In the article by Portnoi et al. (2006) DNA concentration corresponding to 101 – 106 cells was used for the standard curve.  
The final concentration of primer and probe were increased from 0.5 and 0.2μM to 0.9 
and 0.5μM, respectively. Primer concentration was not increased from 0.9μM because of the greater risk of unspecific binding. Probe concentration was increased to 0.5μM due to the difference in hybridisation probe and hydrolysis probe reaction chemistry. To increase the hydrolysis probe concentration further could increase the background fluorescence.    Portnoi et al. (2006) used reagents and qPCR machine from Roche diagnostics, in principle there should be no difference between qPCR machines from two different companies.  A single fluorescein-labelled hybridisation probe and a forward primer with an internal Red640 label at the 3`end was used for Borrelia detection by the hbb gene.  The single labelled hybridisation probe is not hydrolysed by the DNA polymerase and can be reused accounting for the low probe concentration used compared to the cycles 
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ran.  It has been reported that hybridisation probes are more sensitive than hydrolysation probes and produce less background noise than hydrolysation probes (Wilhelm, Pingoud, & Hahn, 2001). Also glass capillary reaction tubes used by Portnoi et 
al. (2006) are reported to be more sensitive than plastic plates for samples with small DNA concentrations (Elenitoba-Johnson, David, Crews, & Wittwer, 2008).  Changes were made on the qPCR program from Portnoi et al. (2006). The initial denaturation time was decreased from 10 to 1 minute respectively. The hbb positive control template is 171bp long and therefore this was considered as sufficient denaturation time. At the start of this experiment qPCR steps were run for 40 cycles, but this was gradually increased to 50, which is very high. The annealing temperature was increased from 50°C to 52°C because primers bonded better with the template DNA strand.   The low primer binding efficiency for the standard curve (figure 4.4) is a clear indication of the need for further optimisation work for this assay.  Human sources of errors cannot be excluded. From the amplification plot for the modified Portnoi qPCR assay (figure 4.3) the parallels are not gathered as close as I would like. It would be better if 3 parallels were used for each dilution instead of 2.      
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6 Conclusion and future perspectives For further research on qPCR detection of Borrelia in human blood samples it would be beneficial to have a better understanding on Borrelia pathogenesis in the human body. Is there a constant flow of spirochetes circulating in the blood or are they only present during certain stages of the disease? To figure this out an idea can be to monitor a control group who has tested positive for LD. Blood samples could be taken regularly and cultured in the modified growth media developed by Eva Sapi et al. (2013). After sufficient incubation time (approximately 16 weeks) qPCR followed by sequencing can be done to confirm the presence of Borrelia bacteria. Another idea worth exploring could be to concentrate the spirochetes present in a blood sample by filtrating a larger volume of blood before DNA isolation, followed by a nested PCR. Increasing the target DNA sequence with PCR followed by qPCR for detection and quantification. But before this the qPCR assay have to work properly.  The hbb gene proved to be difficult to work with and the modified Portnoi qPCR assay needs further optimisation to detect Borrelia in human samples. The hbb gene had little GC percentage and thus the primers had to be very long to obtain a sufficient Tm, making them difficult to work with. Increasing sensitivity with hybridisation probes and glass capillary tubes could be worth exploring in the future.          
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Appendix   
1 Hbb positive control reference gene 
Hbb fragment used as positive control 
 The initial 4bp that was added to the hbb fragment is marked in yellow. (5`-…-3`) 
GCTATTAAAGTAAGGAAATTAGTTTATGTCTTTTTCAAGAAGACCAAAGGTTACTAAGTCAGACATTG
TTGATCAAATAGCTTTGAATATTAAAAATAATAATCTGAAATTAGAAAAAAAATACATAAGACTTGTA
ATAGATGCTTTTTTTGAAGAGCTTAAAAGTAATCT 
 
Reference gene  
Borrelia burgdorferi strain B31 histone-like protein HBbu (hbb) gene, complete cds 
Accession number: U48648.1 (www.ncbi.gov) 
 
 (5`-…-3`) 
TTAAAGTAAGGAAATTAGTTTATGTCTTTTTCAAGAAGACCAAAGGTTACTAAGTCAGACATTGTTGA
TCAAATAGCTTTGAATATTAAAAATAATAATCTGAAATTAGAAAAAAAATACATAAGACTTGTAATAG
ATGCTTTTTTTGAAGAGCTTAAAAGTAATCTTTGTTCGAATAATGTTATTGAGTTTAGATCTTTTGGTA
CATTTGAAGTTAGAAAAAGAAAGGGACGCTTAAATGCTCGAAATCCTCAAACAGGGGAGTATGTTA
AGGTCCTAGATCATCACGTTGCGTATTTTCGTCCAGGCAAAGATTTGAAAGAGAGAGTGTGGGGTAT
CAAAGGTTAA 
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2 Primer and probe binding sites 
Hbb positive control with bound primers and probe. Forward primer, Reverse primer and 
probe 
Life primers and probe  
Amplicon length: 94bp 
Oligo sequence (5´-…-3´) 
GCTATTAAAGTAAGGAAATTAGTTTATGTCTTTTTCAAGAAGACCAAAGGTTACTAAGTCAGACATTG
TTGATCAAATAGCTTTGAATATTAAAAATAATAATCTGAAATTAGAAAAAAAATACATAAGACTTGTA
ATAGATGCTTTTTTTGAAGAGCTTAAAAGTAATCT 
 
Portnoi primers and probe 
Amplicon length: 152bp 
Oligo sequence (5´-…-3´) 
GCTATTAAAGTAAGGAAATTAGTTTATGTCTTTTTCAAGAAGACCAAAGGTTACTAAGTCAGACATTG
TTGATCAAATAGCTTTGAATATTAAAAATAATAATCTGAAATTAGAAAAAAAATACATAAGACTTGTA
ATAGATGCTTTTTTTGAAGAGCTTAAAAGTAATCT 
 
Modified Portnoi primer and probe 
Amplicon length: 157bp 
Oligo sequence (5´-…-3´) 
GCTATTAAAGTAAGGAAATTAGTTTATGTCTTTTTCAAGAAGACCAAAGGTTACTAAGTCAGACATTG
TTGATCAAATAGCTTTGAATATTAAAAATAATAATCTGAAATTAGAAAAAAAATACATAAGACTTGTA
ATAGATGCTTTTTTTGAAGAGCTTAAAAGTAATCT 
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3 Microbe BLAST result  
Table A1: Microbe BLAST results. Data obtained from NCBI.gov.  See figure A1 for Clustal x 
alignment.  
Species Accession number 
B. afzelii (HLJ01) NC_018887.1 
B. valaisiana (VS116) NZ_ABCY02000001.1 
B. burgdorferi (B31) NC_001318.1 
B. garinii (NMJW1) NC_018747.1 
B. garinii (BgVir) NC_017717.1 
B. garinii (PBi) NC_006156.1 
  
 
Figure A1: Clustal x alignment of Microbe BLAST.  See table A1 for species accession number.  
Sequence oligo 5`-…-`3.  
4 Buffers and solutions Tris-EDTA buffer Prepared by Elin skårland Frøyland  EDTA 10μl (10.5M, pH 8.0, Glbiochem) was mixed with Tris-HCl 2μl (1M, pH8.0, Life technologies). And then volume was adjusted to 1000μl with distilled water. The final solution had a pH of 8.0 optimal for DNA isolation. TE-buffer was stored at 4°C.    
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Ammonium hydroxide  A stock solution of ammonium hydroxide (5M, Sigma-Aldrich®) was diluted with sterile water to a 0.7M solution. 
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5 REK application 
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